암 줄기세포 : 기술과 세계 시장

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 암 줄기세포 시장 규모는 2021-2026년간 16.1%의 CAGR로 확대되고, 2021년 21억 달러에서 2026년에는 44억 달러에 달할 것으로 예측됩니다.

부문별로는 유방암 줄기세포가 17.0%, 전립선암 줄기세포가 19.3%의 CAGR로 2021-2026년간 성장할 전망입니다.

세계의 암 줄기세포(Cancer Stem Cells) 시장에 대해 조사했으며, 2026년까지 시장 규모와 예측, 동향 분석, 암 줄기세포 개요, 출시 제품과 파이프라인, 임상시험 평가, 시장 역학, 경쟁 상황, 주요 기업 개요 등의 정보를 제공합니다.

목차

제1장 서론

제2장 요약과 하이라이트

제3장 시장과 기술 배경

• 시장 정의와 범위
• 암 줄기세포 역사
• CSC 합성, 단리 및 동정
• 암 줄기세포 특징
• 종양 세포 전이
• 아포토시스
• 화학요법에 대한 내성
• 줄기세포 분류
• 차별화 능력 기반
• 소스 기반
• 작용기서
• 신호전달 경로 표적화
• CSC 마커 표적화
• miRNA 발현 표적화
• CSC 니치 표적화
• 줄기세포 이식
• 자가
• 동종이계
• 동계
• 암 줄기세포 임상 파이프라인

제4장 시장 역학

• 시장 역학
• 성장 촉진요인
• 암 연구 활동 증가
• 암 발생률과 사망률 증가
• 성장 억제요인
• 윤리적 문제
• 암 줄기세포 치료와 관련된 고비용
• 시장 기회
• 암 줄기세포 조사 증가
• 동물 치료 툴로서의 CSC 구현 성공

제5장 암 종류별 : 시장 내역

• 폐암
• 유방암
• 대장암
• 백혈병
• 흑색종
• 전립선암
• 뇌종양
• 골육종
• 기타

제6장 지역별 : 시장 내역

• 북미
• 미국
• 캐나다
• 멕시코
• 유럽
• 독일
• 프랑스
• 영국
• 이탈리아
• 스페인
• 기타 유럽
• 아시아태평양
• 일본
• 중국
• 호주
• 인도
• 기타 아시아태평양
• 기타 지역(RoW)
• 브라질
• GCC 국가
• 기타 세계 국가

제7장 COVID-19와 줄기세포 연구

• 초기 단계 조사의 영향
• COVID-19용 주류 의약품으로의 줄기세포의 진보
• COVID-19 치료를 위한 줄기세포의 미래

제8장 2021년 줄기세포 치료 비용

• 줄기세포 치료 종류
• 줄기세포 치료가 고가인 이유?
• 줄기세포 치료의 윤리와 규제

제9장 경쟁 상황

• 세계의 기업 순위 분석
• 재생 치료 또는 줄기세포 치료의 스타트업

제10장 기업 개요

• ADNAGEN AG
• ADVANCED CELL DIAGNOSTICS INC.
• APCETH BIOPHARMA
• AVIVA BIOSCIENCES CORP.
• BIONTECH
• BENITEC BIOPHARMA
• CALADRIUS BIOSCIENCES
• CELGENE CORP.
• EPIC SCIENCES INC.
• EXCELLTHERA
• FLUXION BIOSCIENCES INC.
• GALENA BIOPHARMA
• GAMIDA CELL
• GENEXINE
• GERON
• IMMUNOCELLULAR THERAPEUTICS
• ONCOCYTE CORP.
• ONCOMED PHARMACEUTICALS INC.
• PLURISTEM THERAPEUTICS INC.
• SILICON BIOSYSTEMS S.P.A
• SPHERE FLUIDICS LTD.
• VIACYTE INC.

제11장 특허 리스트

• 암 줄기세포에 관한 북미의 특허
• 암 줄기세포에 관한 유럽의 특허
• 암 줄기세포에 관한 아시아태평양의 특허
• 암 줄기세포에 관한 기타 지역의 특허

제12장 부록 : 약어

List of Tables

• Summary Table : Global Market for Cancer Stem Cells, by Cancer Type, Through 2026
• Table 1 : Clinical Trials on Cancer Stem Cells
• Table 2 : Global Market for Cancer Stem Cells, by Cancer Type, Through 2026
• Table 3 : Global Market for Cancer Stem Cells for Lung Cancer, by Region, Through 2026
• Table 4 : Global Market for Cancer Stem Cells for Breast Cancer, by Region, Through 2026
• Table 5 : Global Market for Cancer Stem Cells for Colorectal Cancer, by Region, Through 2026
• Table 6 : Global Market for Cancer Stem Cells for Leukemia, by Region, Through 2026
• Table 7 : Global Market for Cancer Stem Cells for Melanoma, by Region, Through 2026
• Table 8 : Global Market for Cancer Stem Cells for Prostate Cancer, by Region, Through 2026
• Table 9 : Global Market for Cancer Stem Cells for Brain Cancer, by Region, Through 2026
• Table 10 : Global Market for Cancer Stem Cells for Bone Cancer, by Region, Through 2026
• Table 11 : Global Market for Cancer Stem Cells for Other Cancers, by Region, Through 2026
• Table 12 : Global Market for Cancer Stem Cells, by Region, Through 2026
• Table 13 : North American Market for Cancer Stem Cells, by Country, Through 2026
• Table 14 : North American Market for Cancer Stem Cells, by Cancer Type, Through 2026
• Table 15 : European Market for Cancer Stem Cells, by Country, Through 2026
• Table 16 : European Market for Cancer Stem Cells, by Cancer Type, Through 2026
• Table 17 : Asia-Pacific Market for Cancer Stem Cells, by Country, Through 2026
• Table 18 : Asia-Pacific Market for Cancer Stem Cells, by Cancer Type, Through 2026
• Table 19 : RoW Market for Cancer Stem Cells, by Country/Region, Through 2026
• Table 20 : RoW Market for Cancer Stem Cells, by Cancer Type, Through 2026
• Table 21 : Countries Where Stem Cell Research is Most Prevalent
• Table 22 : Adnagen: Product Portfolio
• Table 23 : Advanced Cell Diagnostics: Product Portfolio
• Table 24 : Apceth Biopharma: Product Portfolio
• Table 25 : Aviva Biosciences: Product Portfolio
• Table 26 : BioNTech: Product Portfolio
• Table 27 : Benitec Biopharma: Product Portfolio
• Table 28 : Caladrius Biosciences: Product Portfolio
• Table 29 : Celgene Corp.: Product Portfolio
• Table 30 : Epic Sciences: Product Portfolio
• Table 31 : ExCellThera: Product Portfolio
• Table 32 : Fluxion Biosciences: Product Portfolio
• Table 33 : Galena Biopharma: Product Portfolio
• Table 34 : Gamida Cell: Product Portfolio
• Table 35 : Genexine: Product Portfolio
• Table 36 : Geron: Product Portfolio
• Table 37 : ImmunoCellular Therapeutics: Product Portfolio
• Table 38 : OncoCyte: Product Portfolio
• Table 39 : OncoMed: Product Portfolio
• Table 40 : Pluristem Therapeutics: Product Portfolio
• Table 41 : Silicon Biosystems: Product Portfolio
• Table 42 : Sphere Fluidics: Product Portfolio
• Table 43 : ViaCyte Inc.: Product Portfolio
• Table 44 : Vitatex: Product Portfolio
• Table 45 : List of North American Patents on Cancer Stem Cells
• Table 46 : List of European Patents on Cancer Stem Cells
• Table 47 : List of Asia-Pacific Patents on Cancer Stem Cells
• Table 48 : List of Row Patents on Cancer Stem Cells
• Table 49 : Acronyms Used in This Report

List of Figures

• Summary Figure : Global Market Shares of Cancer Stem Cell, by Cancer Type, 2020
• Figure 1 : Classification of Stem Cells Based on Source
• Figure 2 : Classification of Stem Cells Based on Source and Marker
• Figure 3 : Total Cost per Capita of Cancer in Europe (Direct, Indirect and Informal Costs in Each Country), 2018
• Figure 4 : Incidence of Cancer, 2020
• Figure 5 : Mortality of Cancer, 2020
• Figure 6 : Major Issue in Stem Cell Research in Iran, 2017
• Figure 7 : Number of New Cancer Cases and Mortality Rates Worldwide, by Cancer Type 2020
• Figure 8 : Global Segmentation of the Market for Cancer Stem Cells, by Cancer Type
• Figure 9 : Global Market Shares of Cancer Stem Cells, by Cancer Type, 2020
• Figure 10 : Distribution of New Cases of Lung and Bronchus Cancer, by Age Group, 2020
• Figure 11 : Global Market for Lungs Cancer in Cancer Stem Cells, by Region, 2019-2026
• Figure 12 : Distribution of Female Breast Cancer Cases, by Stage at Diagnosis
• Figure 13 : Breast Cancer Rates in Top Countries, 2020
• Figure 14 : Global Market for Cancer Stem Cells for Breast Cancer, by Region, 2019-2026
• Figure 15 : Incidence of Colorectal Cancer Among More and Less Developed Regions, 2018
• Figure 16 : Global Market for Cancer Stem Cells for Colorectal Cancer, by Region, 2019-2026
• Figure 17 : Incidence and Mortality Rates of Leukemia in the U.S., 2010-2019
• Figure 18 : Global Market for Cancer Stem Cells for Leukemia, by Region, 2019-2026
• Figure 19 : Incidence and Mortality Rates of Melanoma in U.S., 2010-2019
• Figure 20 : Global Market for Cancer Stem Cells for Melanoma, by Region, 2019-2026
• Figure 21 : Distribution of New Cases of Melanoma in the U.S., by Age Group, 2021
• Figure 22 : Global Market for Cancer Stem Cells for Prostate Cancer, by Region, 2019-2026
• Figure 23 : Global Market for Cancer Stem Cells for Brain Cancer, by Region, 2019-2026
• Figure 24 : Global Market for Cancer Stem Cells for Bone Cancer, by Region, 2019-2026
• Figure 25 : Global Market for Cancer Stem Cells for Other Types of Cancer, by Region, 2019-2026
• Figure 26 : Global Market Shares of Cancer Stem Cells, by Region, 2020
• Figure 27 : Five Most Common Sites for Estimated New Cancer Cases and Death in U.S., 2021
• Figure 28 : North American Market Shares of Cancer Stem Cells, by Cancer Type, 2020
• Figure 29 : New Cases of Cancer in Males in the U.S., 2020
• Figure 30 : New Cases of Cancer in Females in the U.S., 2020
• Figure 31 : U.S. Market for Cancer Stem Cells, 2019-2026
• Figure 32 : Distribution of New Cancer Cases in Canada, 2021
• Figure 33 : Canadian Market for Cancer Stem Cells, 2019-2026
• Figure 34 : Cancer Incidence and Mortality in Mexico, 2021
• Figure 35 : Mexican Market for Cancer Stem Cells, 2019-2026
• Figure 36 : Predicted Cancer Mortality in Europe, 2021
• Figure 37 : European Market Shares of Cancer Stem Cells, by Cancer Type, 2020
• Figure 38 : Cancer Incidence and Mortality in Germany, 2020
• Figure 39 : German Market for Cancer Stem Cells, 2019-2026
• Figure 40 : Cancer Incidence and Mortality in France, 2018
• Figure 41 : French Market for Cancer Stem Cells, 2019-2026
• Figure 42 : Cancer Incidence in the U.K., 2018
• Figure 43 : U.K. Market for Cancer Stem Cells, 2019-2026
• Figure 44 : Cancer Incidence in Italy, 2020
• Figure 45 : Italian Market for Cancer Stem Cells, 2019-2026
• Figure 46 : Cancer Incidence in Spain, 2018
• Figure 47 : Spanish Market for Cancer Stem Cells, 2019-2026
• Figure 48 : Rest of European Market for Cancer Stem Cells, 2019-2026
• Figure 49 : Shares of Top Five Countries with Cancer Cases in Asia, 2018
• Figure 50 : Cancer Incidence in Southeast Asia, 2020
• Figure 51 : Asia-Pacific Market Shares of Cancer Stem Cell, by Cancer Type, 2020
• Figure 52 : Cancer Incidence in Japan, by Cancer Type, 2020
• Figure 53 : Cancer Deaths in Japan, by Cancer Type, 2020
• Figure 54 : Budget to Control Cancer in Japan, 2003-2015
• Figure 55 : Japanese Market for Cancer Stem Cells, 2019-2026
• Figure 56 : Cancer Incidence and Mortality in China, 2020
• Figure 57 : Chinese Market for Cancer Stem Cells, 2019-2026
• Figure 58 : Cancer Incidence and Mortality in Australia, 2020
• Figure 59 : Australian Market for Cancer Stem Cells, 2019-2026
• Figure 60 : Cancer Incidence and Mortality in India, 2020
• Figure 61 : Indian Market for Cancer Stem Cells, 2019-2026
• Figure 62 : Rest of Asia-Pacific Market for Cancer Stem Cells, 2019-2026
• Figure 63 : Distribution of New Cancer Cases in Latin America and the Caribbean, by Cancer Type, 2020
• Figure 64 : Distribution of Cancer Deaths in Latin America and the Caribbean, by Cancer Type, 2020
• Figure 65 : RoW Market Shares of Cancer Stem Cells, by Cancer Type, 2020
• Figure 66 : Cancer Incidence and Mortality in Brazil, 2020
• Figure 67 : Brazilian Market for Cancer Stem Cells, 2019-2026
• Figure 68 : Brazilian Market for Cancer Stem Cells, 2019-2026
• Figure 69 : Most Common Cancer Cases in Qatar, by Incidence and Mortality, 2020
• Figure 70 : GCC Countries Market for Cancer Stem Cells, 2019-2026
• Figure 71 : Other Countries Market for Cancer Stem Cells, 2019-2026
• Figure 72 : Using MSC Therapy in COVID-19 Patients
• Figure 73 : How Much Does Stem Cell Therapy Cost?
• Figure 74 : Global Ranking in the Market for Cancer Stem Cells, by Pharmaceutical Company, 2020
• Figure 75 : Global Ranking in the Market for Cancer Stem Cells, by Start-up Pharmaceutical Company, 2020

Highlights:

The global market for cancer stem cells should grow from $2.1 billion in 2021 to $4.4 billion by 2026, at compound annual growth rate (CAGR) of 16.1% for the period of 2021-2026.

Cancer stem cells market for breast cancer should grow from $429.6 million in 2021 to $940.6 million by 2026, at a CAGR of 17.0% for the period of 2021-2026.

Cancer stem cells market for prostate cancer should grow from $378.3 million in 2021 to $913.2 million by 2026, at a CAGR of 19.3% for the period of 2021-2026.

Report Scope:

This research report presents an in-depth analysis of the global cancer stem cells market by cancer type and geographic markets. The report includes key inhibitors that affect various factors that help in growth of cancer stem cells. The report discusses the roles of supply chain members from manufacturers to researchers. The report has an in-depth analysis of key companies operating in the global cancer stem cells market. In-depth patent analysis in the report will focus on providing extensive technological trends across years and geographies such as the U.S., Europe and China.

The cancer stem cells market is mainly segmented into two major components: cancer type and geography. Based on cancer type, the market is segmented into lung cancer, breast cancer, colorectal cancer, leukemia, melanoma, prostate cancer, brain cancer, bone cancer and other types of cancer. The market is segmented by geography into North America, Europe, Asia-Pacific and RoW.

Report Includes:

• 50 tables
• An overview of the global market and technologies for cancer stem cells
• Estimation of the market size and analyses of global market trends, with data from 2019, 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
• Coverage of history, synthesis, isolation, identification and characteristics of cancer stem cells, and description of stem cell transplant types i.e., autologous, allogeneic, and syngeneic
• Detailed description of cancer stem cells, its pathophysiology and affects and major advancement of the industry and discussion on side effects of stem cells implantation
• Discussion on the future of stem cells for the treatment of COVID-19 and information about advancing stem cells to mainstream medicines for COVID-19
• Assessment of regulatory structure, pricing, and reimbursement scenarios; marketed and pipeline (R&D) products, and clinical trials
• Identification of market drivers, restraints and other forces impacting the global market and evaluation of current market size and forecast
• Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
• Comprehensive company profiles of the leading players of the industry including AdnaGen AG, Advanced Cell Diagnostics Inc., BioNTech, Caladrius Biosciences Inc., Celgene Corp., ExCellThera, Gamida Cell, Silicon Biosystems and ViaCyte Inc.

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• What's New in This Report?
• Scope of Report
• Information Sources and Methodology
• Intended Audience
• Geographic Breakdown
• Analyst's Credentials
• BCC Custom Research
• Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

• Market Definition and Scope
• History of Cancer Stem Cells
• Synthesis, Isolation and Identification of CSCs
• Characteristics of Cancer Stem Cells
• Metastasizing Tumor Cells
• Apoptosis
• Resistance to Chemotherapy
• Stem Cell Classification
• Based on Ability to Differentiate
• Based on Source
• Mechanism of Action
• Targeting Signaling Pathways
• Targeting CSCs Markers
• Targeting miRNA Expression
• Targeting CSCs' Niche
• Stem Cell Transplants
• Autologous
• Allogeneic
• Syngeneic
• Cancer Stem Cell Clinical Pipeline

Chapter 4 Market Dynamics

• Market Dynamics
• Drivers
• Increase in Cancer Research Activities
• Increase in Incidence and Mortality Rate of Cancer
• Restraints
• Ethical Issues
• High Cost Associated with Cancer Stem Cell Therapeutics
• Opportunity
• Increasing Cancer Stem Cell Research
• Successful Implementation of CSC as a Therapeutic Tool in Animals

Chapter 5 Market Breakdown by Cancer Type

• Lung Cancer
• Incidence of Lung Cancer
• Risk Factors
• Types of Lung Cancer
• Site of Lung Tumor Initiation
• Lung Cancer Stem Cells as Therapeutic Targets
• Breast Cancer
• Incidence and Mortality Rate of Breast Cancer
• Types of Breast Cancer
• Site of Tumor Initiation
• Breast Cancer Stem Cells as Therapeutic Targets
• Colorectal Cancer
• Incidence and Mortality of Colorectal Cancer
• Colorectal Cancer Stem Cells as Therapeutic Targets
• Leukemia
• Incidence and Mortality of Leukemia
• Leukemia Stem Cells as Therapeutic Targets
• Melanoma
• Incidence and Mortality of Melanoma
• Melanoma Cancer Stem Cells as Therapeutic Targets
• Prostate Cancer
• Incidence and Mortality Rate of Prostate Cancer
• Prostate Cancer Stem Cells as Therapeutic Targets
• Brain Cancer
• Incidence of Brain Cancer
• Brain Cancer Stem Cells as Therapeutic Targets
• Bone Cancer
• Bone Cancer Stem Cells as Therapeutic Targets
• Others

Chapter 6 Market Breakdown by Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• Japan
• China
• Australia
• India
• Rest of Asia-Pacific
• Rest of the World (RoW)
• Brazil
• GCC Countries
• Rest of the World Countries

Chapter 7 COVID-19 and Stem Cell Research

• Impact of Early-Stage Research
• Advancing Stem Cells to Mainstream Medicines for COVID-19
• The Future of Stem Cells for the Treatment of COVID-19

Chapter 8 Cost of Stem Cell Therapy in 2021

• Types of Stem Cell Therapy
• Stem Cell Therapy is Expensive- Why?
• Ethics and Regulations for Stem Cell Therapy

Chapter 9 Competitive Landscape

• Global Company Ranking Analysis
• Start-up on Regenerative Therapeutics or Stem Cell Therapeutics

Chapter 10 Company Profiles

• ADNAGEN AG
• ADVANCED CELL DIAGNOSTICS INC.
• APCETH BIOPHARMA
• AVIVA BIOSCIENCES CORP.
• BIONTECH
• BENITEC BIOPHARMA
• CALADRIUS BIOSCIENCES
• CELGENE CORP.
• EPIC SCIENCES INC.
• EXCELLTHERA
• FLUXION BIOSCIENCES INC.
• GALENA BIOPHARMA
• GAMIDA CELL
• GENEXINE
• GERON
• IMMUNOCELLULAR THERAPEUTICS
• ONCOCYTE CORP.
• ONCOMED PHARMACEUTICALS INC.
• PLURISTEM THERAPEUTICS INC.
• SILICON BIOSYSTEMS S.P.A
• SPHERE FLUIDICS LTD.
• VIACYTE INC.
• VITATEX INC.

Chapter 11 List of Patents

• North American Patents on Cancer Stem Cells
• European Patents on Cancer Stem Cells
• Asia-Pacific Patents on Cancer Stem Cells
• RoW Patents on Cancer Stem Cells

Chapter 12 Appendix: Acronyms